Scientist and Principal Investigator at Sri Shankara Cancer Hospital and Research Centre
Dr. Namani's research focuses on the molecular mechanisms driving cancer, particularly the NRF2 signaling pathway, cancer omics, and therapeutic resistance.
Dr. Namani has expertise in Cancer genomics, Drug Discovery, Bioinformatics, and Computational Biology. He integrates multi-omics approaches and AI/ML driven models to identify biomarkers, therapeutic targets, and precision oncology strategies.